These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
498 related items for PubMed ID: 12421226
1. Comparative yield of HCV RNA testing in blood donors screened by 2.0 versus 3.0 antibody assays. Galel SA, Strong DM, Tegtmeier GE, Holland PV, Kuramoto IK, Kemper M, Pietrelli L, Gallarda J. Transfusion; 2002 Nov; 42(11):1507-13. PubMed ID: 12421226 [Abstract] [Full Text] [Related]
4. Detection of HIV-1 and HCV infections among antibody-negative blood donors by nucleic acid-amplification testing. Stramer SL, Glynn SA, Kleinman SH, Strong DM, Caglioti S, Wright DJ, Dodd RY, Busch MP, National Heart, Lung, and Blood Institute Nucleic Acid Test Study Group. N Engl J Med; 2004 Aug 19; 351(8):760-8. PubMed ID: 15317889 [Abstract] [Full Text] [Related]
5. Impact of HCV 3.0 EIA relative to HCV 2.0 EIA on blood-donor screening. Tobler LH, Stramer SL, Lee SR, Masecar BL, Peterson JE, Davis EA, Andrews WE, Brodsky JP, Kleinman SH, Phelps BH, Busch MP. Transfusion; 2003 Oct 19; 43(10):1452-9. PubMed ID: 14507279 [Abstract] [Full Text] [Related]
8. Hepatitis C virus infection in volunteer blood donors in Taiwan. Evaluation by hepatitis C antibody assays and the polymerase chain reaction. Wang JT, Wang TH, Sheu JC, Tsai SJ, Hsieh YS, Lin DT, Wang CY, Chen DS. Arch Pathol Lab Med; 1993 Feb 19; 117(2):152-6. PubMed ID: 8381269 [Abstract] [Full Text] [Related]
10. Validation of the NucliSens Extractor combined with the AmpliScreen HIV version 1.5 and HCV version 2.0 test for application in NAT minipool screening. Jongerius JM, Sjerps M, Cuijpers HT, van Drimmelen HA, van der Poel CL, Reesink HW, Molijn MH, Peeters GA, Peeters TP, Lelie PN. Transfusion; 2002 Jun 19; 42(6):792-7. PubMed ID: 12147034 [Abstract] [Full Text] [Related]
11. Correlates of hepatitis C virus (HCV) RNA negativity among HCV-seropositive blood donors. Busch MP, Glynn SA, Stramer SL, Orland J, Murphy EL, Wright DJ, Kleinman S, NHLBI Retrovirus Epidemiology Donor Study (REDS) Group. Transfusion; 2006 Mar 19; 46(3):469-75. PubMed ID: 16533292 [Abstract] [Full Text] [Related]
13. Outcome of an optional HCV screening program for blood transfusion recipients in Ireland. Davoren A, Dillon AD, Power JP, Donnellan J, Quinn JM, Willis JW, Lawlor EM, O'Riordan JM. Transfusion; 2002 Nov 19; 42(11):1501-6. PubMed ID: 12421225 [Abstract] [Full Text] [Related]
19. [Significance of alanine aminotransferase screening in blood donors for risk reduction of hepatitis B and C transmission by haemotherapy]. Kusendová K, Gavorník P, Sabaka P, Sviteková K. Vnitr Lek; 2016 Jan 19; 62(1):9-16. PubMed ID: 26967232 [Abstract] [Full Text] [Related]
20. Evaluation of indeterminate c22-3 reactivity in volunteer blood donors. Tobler LH, Busch MP, Wilber J, Dinello R, Quan S, Polito A, Kochesky R, Bahl C, Nelles M, Lee SR. Transfusion; 1994 Feb 19; 34(2):130-4. PubMed ID: 8310482 [Abstract] [Full Text] [Related] Page: [Next] [New Search]